Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 2/2021

Inhalt (25 Artikel)

Open Access Review

Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis

Keiichiro Mori, Hadi Mostafaei, Noriyoshi Miura, Pierre I. Karakiewicz, Stefano Luzzago, Manuela Schmidinger, Andreas Bruchbacher, Benjamin Pradere, Shin Egawa, Shahrokh F. Shariat

Original Article

Identification of STXBP6-IRF1 positive feedback loop in regulation of PD-L1 in cancer

Yanbin Liu, Zhicong Huang, Yanli Wei, Mingming Zhang, Xingzhi Li, Shulan Yang, Haihe Wang

Original Article

Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer

Aung Kyi Thar Min, Kosaku Mimura, Shotaro Nakajima, Hirokazu Okayama, Katsuharu Saito, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo, Motonobu Saito, Zenichiro Saze, Tomoyuki Momma, Shinji Ohki, Koji Kono

Original Article

Improved survival in patients with thyroid function test abnormalities secondary to immune-checkpoint inhibitors

Joana Lima Ferreira, Cláudia Costa, Bernardo Marques, Sofia Castro, Margarida Victor, Joana Oliveira, Ana Paula Santos, Inês Lucena Sampaio, Hugo Duarte, Ana Paula Marques, Isabel Torres

Original Article

B7-H3 is spliced by SRSF3 in colorectal cancer

Chunxia Zhang, Yinshuang Chen, Fuchao Li, Man Yang, Fanyi Meng, Yawen Zhang, Weichang Chen, Weipeng Wang

Open Access Original Article

Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1

Anna Makowska, Selina Meier, Lian Shen, Pierre Busson, Valentin Baloche, Udo Kontny

Original Article

A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors

Kiyohiro Ando, Kazuyuki Hamada, Midori Shida, Ryotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, Hiroto Matsui, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Makoto Watanabe, Rie Onoue, Junji Tsurutani, Kiyoshi Yoshimura, Takuya Tsunoda, Shinichi Kobayashi, Satoshi Wada

Original Article

Expression pattern, regulation, and clinical significance of TOX in breast cancer

Mohit Arora, Sarita Kumari, Jay Singh, Anita Chopra, Shyam S. Chauhan

Original Article

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

Yan Wang, Haiqing Ni, Shuaixiang Zhou, Kaijie He, Yarong Gao, Weiwei Wu, Min Wu, Zhihai Wu, Xuan Qiu, Ying Zhou, Bingliang Chen, Donghui Pan, Chenrong Huang, Mingzhu Li, Yicong Bian, Min Yang, Liyan Miao, Junjian Liu

Original Article

Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma

Zhi-Qiang Hu, Hao-Yang Xin, Chu-Bin Luo, Jia Li, Zheng-Jun Zhou, Ji-Xue Zou, Shao-Lai Zhou

Original Article

Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors

Jenny Ling-Yu Chen, Chun-Kai Pan, Yu-Sen Huang, Ching-Yi Tsai, Chun-Wei Wang, Yu-Li Lin, Sung-Hsin Kuo, Ming-Jium Shieh

Open Access Original Article

Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study

M. A. Amrein, E. D. Bührer, M. L. Amrein, Q. Li, S. Rothschild, C. Riether, R. Jaggi, S. Savic-Prince, L. Bubendorf, O. Gautschi, A. F. Ochsenbein

Open Access Original Article

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma

Li-Li Liu, Shi-Wen Zhang, Xue Chao, Chun-Hua Wang, Xia Yang, Xin-Ke Zhang, Yan-lin Wen, Jing-Ping Yun, Rong-Zhen Luo

Original Article

Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy

Sumi Yun, Jiwon Koh, Soo Kyung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Joong Do Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee

Original Article

The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy

Shinya Urakawa, Makoto Yamasaki, Tomoki Makino, Yukinori Kurokawa, Kei Yamamoto, Kumiko Goto, Miya Haruna, Michinari Hirata, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Tsunekazu Mizushima, Eiichi Sato, Masaki Mori, Yuichiro Doki, Hisashi Wada

Open Access Original Article

PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients

A. Raniszewska, H. Vroman, D. Dumoulin, R. Cornelissen, J. G. J. V. Aerts, J. Domagała-Kulawik

Original Article

Tumor cell-derived autophagosomes (DRibbles)-activated B cells induce specific naïve CD8+ T cell response and exhibit antitumor effect

Tian-Yu Zhang, Hong-Yan Ren, Ning Pan, Hui-Xia Dong, Si-Min Zhao, Zhi-Fa Wen, Xu-Ru Wang, Li-Xin Wang

Original Article

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

Georgia M. Beasley, Aaron D. Therien, Eda K. Holl, Rami Al-Rohil, Maria Angelica Selim, Nellie E. Farrow, Liuliu Pan, Premi Haynes, Yan Liang, Douglas S. Tyler, Brent A. Hanks, Smita K. Nair

Original Article

T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer

Takashi Akiyoshi, Osamu Gotoh, Norio Tanaka, Kazuma Kiyotani, Noriko Yamamoto, Masashi Ueno, Yosuke Fukunaga, Seiichi Mori

Open Access Original Article

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer

Alexandra Leary, Catherine Genestie, Félix Blanc-Durand, Sébastien Gouy, Ariane Dunant, Amandine Maulard, Françoise Drusch, Bianca Cheaib, Judith Michels, Enrica Bentivegna, Audrey LeFormal, Soizick Mesnage, Philippe Morice, Patricia Pautier, Aya S. Khairallah

Original Article

Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody

Shijin Yuan, Yan Xia, Lihong Shen, Liuqing Ye, Lisha Li, Lifen Chen, Xinyou Xie, Haizhou Lou, Jun Zhang

Open Access Original Article

Curdlan, zymosan and a yeast-derived β-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants

Priscilla de Graaff, Cor Berrevoets, Christiane Rӧsch, Henk A. Schols, Kees Verhoef, Harry J. Wichers, Reno Debets, Coen Govers

Open Access Research Report

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients

Omar Hasan Ali, Fiamma Berner, Christoph Jakob Ackermann, Sandra Stephanie Ring, Alexandre Moulin, Joachim Müller, Eva Markert, Oltin Tiberiu Pop, Stefanie Müller, Stefan Diem, Thomas Hundsberger, Lukas Flatz

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.